CLINICAL SUPPLY REGULATORY ARTICLES

Logistics-transportation-GettyImages-1384980908 Vendor/Supplier Management To Maintain A Drug's Safety Profile In End-To-End Supply Chain Planning

FDA 21 CFR 211 requires vendor qualification as a part of the validation process and EU GxP requirements expect robust vendor management, and we expect regulators to issue firmer guidance sooner rather than later. Don't let your pharma/biotech fall short.

CLINICAL SUPPLY REGULATORY VIDEOS

Choosing the right clinical packaging and supply chain partner to support APAC studies can vary significantly based upon which countries are involved and the types of services required.

Decentralized clinical trials are made up of a multitude of elements, from in home clinical capabilities, logistics, digital platforms, and technology, to global reach and more. This webinar shares important factors to consider to build your DCT ‘molecule’ successfully.

Understand how free trade zones work, and explore a flexible and cost efficient way to supply clinical trials in China and around the globe.

In the era of seamless development, reducing time to the clinic and getting rapid approval is key. An integrated approach can accelerate timelines, avoid communication pitfalls, and improve outcomes.

CLINICAL SUPPLY REGULATORY RESOURCES